Maternal and infant health study
Part of Genetic & congenital, Heart & circulation, Women’s health & pregnancy clinical trials.
This study looks at the health of mothers and their babies during and after pregnancy. It may help find ways to improve care for pregnant women and their newborns.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial follows women who have had preeclampsia to learn more about their health after pregnancy. It collects blood and tissue samples to find markers that could improve future care.
This study looks at how cells in the placenta handle stress in pregnancies with complications like preeclampsia or poor fetal growth. It aims to understand why some placentas don't work well, which could lead to better treatments.
This study tests a support program for Black and Latina pregnant people to help reduce pregnancy complications like preeclampsia. It uses text messaging and coaching to improve care and outcomes.
This study collects pregnancy-related samples and health information to help researchers learn more about conditions like preeclampsia and prematurity. Your participation may help future studies, but it usually involves whether you can safely consent and whether the pregnancy is continuing at the time of recruitment.
This study looks at placental tissue to better understand pregnancy conditions like preeclampsia and recurrent miscarriage. It may help improve future care for these conditions.
This study looks at heart and metabolic health during late pregnancy and after delivery, tracking both healthy women and those with complications like high blood pressure or diabetes in pregnancy. The goal is to understand how these risks change and what can be done to improve long-term health.
Hear when a new Infant, Premature, Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.